Tonix Pharmaceuticals to Present Poster on Tonmya(TM) at the 2025 American College of Rheumatology (ACR) Convergence
(NASDAQ:TNXP), CHATHAM, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology company, announced today that a poster on Tonmya(TM) (cyclobenzaprine HCl sublingual tablets), which was investigated as TNX-102 SL, will be presented by Dr. Gregory Sullivan, M.D., Chief Medical Officer of Tonix Pharmaceuticals, […]